Bufalari A, Miller S M, Giannoni C, Short C E
Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York 14853, USA.
J Am Anim Hosp Assoc. 1998 Jan-Feb;34(1):84-91. doi: 10.5326/15473317-34-1-84.
Cardiovascular, pulmonary, and quantitative electroencephalographic parameters were assessed in 12 anesthetized dogs to determine the compatibility of the injectable anesthetic propofol with halothane and isoflurane. No cases of apnea were observed during induction of anesthesia. An adequate level of anesthesia was established in each protocol as judged by both the lack of response to mechanical noxious stimuli (i.e., tail clamping) and evidence of reduction in total amplitude of brain wave activity. The initial propofol-mediated decrease in arterial blood pressure continued during either halothane (52.4%) or isoflurane (38%) anesthesia without a simultaneous increase in heart rate. The results of this study suggest that propofol, in combination with inhalant agents, can be used effectively and safely for canine anesthesia in veterinary practice.
对12只麻醉犬的心血管、肺部和定量脑电图参数进行了评估,以确定注射用麻醉药丙泊酚与氟烷和异氟烷的兼容性。麻醉诱导期间未观察到呼吸暂停病例。根据对机械性有害刺激(即夹尾)无反应以及脑电波活动总振幅降低的证据判断,每个方案均建立了足够的麻醉水平。在氟烷(52.4%)或异氟烷(38%)麻醉期间,最初由丙泊酚介导的动脉血压下降持续存在,且心率没有同时增加。本研究结果表明,丙泊酚与吸入性药物联合使用,在兽医实践中可有效、安全地用于犬类麻醉。